It has been shown that estradiol-induced PIM-1 overexpression in breast cancer leads to the phosphorylation of key proteins, which in turn suppresses the expression of cell cycle inhibitors (CDKN1A and CDKN2B) [50]. This evidence concerns the gene PIM1 and breast carcinoma.